Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28312

1.

Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.

Silva I, Teixeira A, Oliveira J, Almeida I, Almeida R, Águas A, Vasconcelos C.

Clin Rev Allergy Immunol. 2015 Jul 4. [Epub ahead of print]

PMID:
26142066
2.

Matrix remodeling in systemic sclerosis.

Leask A.

Semin Immunopathol. 2015 Jul 4. [Epub ahead of print]

PMID:
26141607
3.

Acquired partial lipodystrophy is associated with increased risk for developing metabolic abnormalities.

Akinci B, Koseoglu FD, Onay H, Yavuz S, Altay C, Simsir IY, Ozisik S, Demir L, Korkut M, Yilmaz N, Ozen S, Akinci G, Atik T, Calan M, Secil M, Comlekci A, Demir T.

Metabolism. 2015 Jun 10. pii: S0026-0495(15)00165-1. doi: 10.1016/j.metabol.2015.06.004. [Epub ahead of print]

PMID:
26139569
4.

Correlation of clinical tools to determine activity of localised scleroderma in pediatric patients.

Garcia-Romero M, Laxer R, Pope E.

Br J Dermatol. 2015 Jul 2. doi: 10.1111/bjd.14001. [Epub ahead of print]

PMID:
26138783
5.

Notch intracellular domain overexpression in adipocytes confers lipodystrophy in mice.

Chartoumpekis DV, Palliyaguru DL, Wakabayashi N, Khoo NK, Schoiswohl G, O'Doherty RM, Kensler TW.

Mol Metab. 2015 May 2;4(7):543-50. doi: 10.1016/j.molmet.2015.04.004. eCollection 2015 Jul.

PMID:
26137442
Free Article
6.

Beneficial effect of the 5-HT1A receptor agonist buspirone on esophageal dysfunction associated with systemic sclerosis: A pilot study.

Karamanolis GP, Panopoulos S, Karlaftis A, Denaxas K, Kamberoglou D, Sfikakis PP, Ladas SD.

United European Gastroenterol J. 2015 Jun;3(3):266-71. doi: 10.1177/2050640614560453.

PMID:
26137301
7.

How are cancer and connective tissue diseases related to sarcoidosis?

Chopra A, Judson MA.

Curr Opin Pulm Med. 2015 Jun 30. [Epub ahead of print]

PMID:
26132816
8.

Genomic diagnosis by whole genome sequencing in a Korean family with atypical progeroid syndrome.

Lee S, Park SM, Kim HJ, Kim JW, Yu DS, Lee YB.

J Dermatol. 2015 Jun 29. doi: 10.1111/1346-8138.13005. [Epub ahead of print]

PMID:
26122271
9.
10.

Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.

Miehle K, Porrmann J, Mitter D, Stumvoll M, Glaser C, Fasshauer M, Hoffmann K.

Clin Endocrinol (Oxf). 2015 Jun 28. doi: 10.1111/cen.12837. [Epub ahead of print]

PMID:
26119484
11.

Scleroderma and pulmonary hypertension complicating two pregnancies: use of neuraxial anesthesia, general anesthesia, epoprostenol and a multidisciplinary approach for cesarean delivery.

Moaveni D, Cohn J, Brodt J, Hoctor K, Ranasinghe J.

Int J Obstet Anesth. 2015 May 8. pii: S0959-289X(15)00077-1. doi: 10.1016/j.ijoa.2015.05.001. [Epub ahead of print]

PMID:
26119257
12.

Mice overexpressing integrin αv in fibroblasts exhibit dermal thinning of the skin.

Wang Z, Jinnin M, Kobayashi Y, Kudo H, Inoue K, Nakayama W, Honda N, Makino K, Kajihara I, Makino T, Fukushima S, Inagaki Y, Ihn H.

J Dermatol Sci. 2015 Jun 22. pii: S0923-1811(15)30011-6. doi: 10.1016/j.jdermsci.2015.06.008. [Epub ahead of print]

PMID:
26117269
13.

Regenerative Approach to Scleroderma with Fat Grafting.

Magalon G, Daumas A, Sautereau N, Magalon J, Sabatier F, Granel B.

Clin Plast Surg. 2015 Jul;42(3):353-64. doi: 10.1016/j.cps.2015.03.009. Review.

PMID:
26116941
14.

Consensus best practice pathway of the UK Systemic Sclerosis Study Group: digital vasculopathy in systemic sclerosis.

Hughes M, Ong VH, Anderson ME, Hall F, Moinzadeh P, Griffiths B, Baildam E, Denton CP, Herrick AL.

Rheumatology (Oxford). 2015 Jun 26. pii: kev201. [Epub ahead of print]

PMID:
26116156
15.

Polymorphisms in adiponectin receptor genes are associated with lipodystrophy-related phenotypes in HIV-infected patients receiving antiretroviral therapy.

Castilhos JK, Sprinz E, Lazzaretti RK, Kuhmmer R, Mattevi VS.

HIV Med. 2015 Jun 25. doi: 10.1111/hiv.12250. [Epub ahead of print]

PMID:
26111083
16.

Optimal management of digital ulcers in systemic sclerosis.

Abraham S, Steen V.

Ther Clin Risk Manag. 2015 Jun 15;11:939-47. doi: 10.2147/TCRM.S82561. eCollection 2015. Review.

17.

Pathogenesis of Systemic Sclerosis.

Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE.

Front Immunol. 2015 Jun 8;6:272. doi: 10.3389/fimmu.2015.00272. eCollection 2015. Review.

18.

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients.

Rice LM, Padilla CM, McLaughlin SR, Mathes A, Ziemek J, Goummih S, Nakerakanti S, York M, Farina G, Whitfield ML, Spiera RF, Christmann RB, Gordon JK, Weinberg J, Simms RW, Lafyatis R.

J Clin Invest. 2015 Jul 1;125(7):2795-807. doi: 10.1172/JCI77958. Epub 2015 Jun 22.

PMID:
26098215
19.

Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders.

Verolet CM, Delhumeau-Cartier C, Sartori M, Toma S, Zawadynski S, Becker M, Bernasconi E, Trellu LT, Calmy A; LIPO Group Metabolism.

AIDS Res Ther. 2015 Jun 20;12:21. doi: 10.1186/s12981-015-0061-z. eCollection 2015.

20.

Increased Expression of NAPDH Oxidase 4 (NOX4) in Systemic Sclerosis Dermal Fibroblasts: Regulation by Transforming Growth Factor ß.

Piera-Velazquez S, Makul A, Jimenez SA.

Arthritis Rheumatol. 2015 Jun 19. doi: 10.1002/art.39242. [Epub ahead of print]

PMID:
26096997
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk